Localization and orientation of TMEM70 protein in the inner mitochondrial membrane  by Hejzlarová, K. et al.
Energy metabolism has emerged as a new target-pathway for de-
velopment of new anti-tubercular drugs [1], which are urgently needed
to combat concomitantly emerging drug-resistant bacterial strains. A
new ATP synthase inhibitor [2], the diarylquinoline TMC207, acts in a
highly selective manner with strong afﬁnity for ATP synthase from
Mycobacterium tuberculosis and only minimal effect on the human
homologue [3]. These features are prerequisite for clinical application
of ATP synthase inhibitors and make TMC207 a promising drug
candidate for shortening and simplifying tuberculosis chemotherapy.
We used biochemical assays and binding studies to characterize
the interaction between TMC207 and ATP synthase [3]. Using
inverted membrane vesicles from the non-pathogenic strain M. bovis
BCG [4] we show that TMC207 acts independent of the proton motive
force and does not compete with protons for a common binding site.
The drug is active on mycobacterial ATP synthesis at neutral and
acidic pH with no signiﬁcant change in afﬁnity between pH 5.25 and
pH 7.5 (IC50 = 5-10 nM), indicating that the protonated form of
TMC207 is the active drug entity. The interaction of TMC207 with ATP
synthase can be explained by a one-site binding mechanism, the
drug molecule thus binds to a deﬁned binding site on ATP synthase.
TMC207 afﬁnity for its target decreases with increasing ionic
strength, suggesting that electrostatic forces play a signiﬁcant role
in drug binding. These results will be discussed in view of existing
docking studies and may provide input for structure-based design of
ATP synthase inhibitors. Moreover, the high afﬁnity of TMC207
observed at low proton motive force and low pH values may in part
explain the exceptional ability of this compound to efﬁciently kill
mycobacteria in different microenvironments.
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Isolated ATP synthase deﬁciency of nuclear origin leads to a rather
frequent fatal neonatal encephalo-cardiomyopathy (OMIM604273).
The most common cause of the disease is c.317-2ANG mutation in
TMEM70 gene, coding for speciﬁc factor of mitochondrial ATP
synthase biogenesis with unknown function [1]. Characterization of
TMEM70 protein properties is thus necessary for elucidation of
its biological role and better understanding of the pathogenic
mechanism of the disease. In this study we analyzed in detail the
biosynthesis and presumed mitochondrial localization of the protein
using cells expressing GFP- or FLAG-tagged forms of TMEM70 protein
as the experimental model. We have found that TMEM70 gene
encoded precursor of 29 kDa is processed into 21 kDa mature protein.
The import study revealed that the TMEM70 protein is processed
after transport into mitochondrial matrix, but the level of transported
protein and its cellular content are very low. Immuno-cytochemical
analysis and fractionation of mitochondria conﬁrmed the localization
of the TMEM70 protein in the inner mitochondrial membrane [2].
Accessibility of the tagged forms of TMEM70 protein to trypsin
followed by electrophoretic or microscopic analysis demonstrated the
orientation of C- and N- protein termini into mitochondrial matrix.
2D BN/SDS electrophoretic analysis of digitonin-solubilized proteins
further showed, that TMEM70 protein is able either form an
oligomeric structures or associate with other, yet unknown proteins.
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Introduction and aim
In order to develop a ﬂow reaction chamber for the continuous cell
free protein synthesis, one key challenge is to provide energy in form
of Adenosine 5′-triphosphate (ATP) for the process. To feed the
system with ATP molecules from an external source is one strategy to
solve this problem. However in this case, the major drawback is that
the reaction products Adenosine 5′-diphosphate (ADP) and phos-
phate accumulate in the reaction solution and have to be removed
frequently. Another approach is the direct regeneration of ATP from
ADP and the phosphate molecule within the reaction compartment.
Therefore, our aim is to isolate the ATP-Synthases from Escherichia
coli and to immobilize these proteins onto custom made carrier
membranes. In the presented work, an ATP regeneration module is
designed employing computational modeling to transfer a batch
reaction into a continuous protein synthesis process.
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